Skip to content

Type: White Papers

White Paper | Conference on Clinical Cancer Research 2015 – Panel 3 | The Blurring of Phase 1, 2 and 3 Trials in Oncology: Expansion Cohorts in Phase 1 Trials

White Paper | Conference on Clinical Cancer Research 2015 – Panel 2 | Capturing Symptomatic Adverse Events From the Patients’ Perspective: The Potential Role of the National Cancer Institute’s PRO-CTCAE Measurement System

White Paper | Conference on Clinical Cancer Research 2015 – Panel 1 | Modernizing Measurement of Tumor Response to Therapy: Application to Immunotherapeutics

White Paper | The New Role of Academia in Drug Development

White Paper | Eliminating Breast Cancer Health Disparities: Communicating to At-Risk Populations

White Paper | Examining Manufacturing Readiness for Breakthrough Drug Development